Audience and Accreditation
|Type: AMA PRA Category 1 Credit(s)™||Estimated Time: 9 hour(s)||Release Date: 10/1/11||Expiration Date: 10/23/13|
Credit Statement for AMA PRA Category 1 Credit(s)™: Clinical Tools, Inc. designates this enduring material for a maximum of 9 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- A letter of completion for up to 9 hour(s) is available for non-physicians.
A score of 70% on the post-test is required to complete the program.
Professional Practice Gaps: Read More
This program is designed to change: Read More
Expand your practice to comply with the regulations and requirements of office based buprenorphine treatment
Relate buprenorphine's pharmacological properties to its drug effects and understand the physiological effects of opioids and opioid treatments on patients
Identify, assess, and diagnose opioid use and dependence in your patients
Utilize medical and substance abuse history information to assess your patients in terms of suitability of treatment with buprenorphine
Provide effective and successful treatment to your patients throughout the phases of buprenorphine treatment: induction, maintenance, and discontinuation, and deal with complications that arise
Assess and adapt treatment guidelines to best treat your patients from specific patient populations, including those with psychiatric comorbidities, adolescents, the elderly, pregnant women, methadone transfers, and patients with pain
Prescribe, refer, or implement appropriate psychosocial therapies for treating opioid dependence
Program Activity Syllabus